太空飞行期间眼科药物的生物物理学:微重力中的眼液动力学和药物动力学原理
Hamza Memon1, Joshua Ong2, Ethan Waisberg3
1Texas A&M School of Medicine, Bryan, TX, United States.
Life sciences in space research
|July 27, 2024
概括
太空飞行需要新的方法来治疗眼睛疾病. 这项研究研究了微重力如何影响局部眼滴和视内注射,这对宇航员的眼睛健康至关重要.
科学领域:
- 眼科医生 眼科 眼科
- 航空航天医学 航空航天医学
- 药理动力学 药理动力学
背景情况:
- 太空飞行正在扩大,增加了对微重力中有效医疗保健解决方案的需求.
- 由于太空环境的独特挑战,眼睛健康是宇航员的重要关注点.
研究的目的:
- 调查太空飞行期间眼部疾病的药理管理.
- 分析微重力对眼药物输送和药理动学的影响.
主要方法:
- 关于在太空中治疗眼病的当前文献的综述.
- 对微重力中的流体动力学和生理变化的分析与药物输送相关.
- 作为输送方法,对局部眼滴和视内注射进行检查.
主要成果:
- 微重力显著改变局部眼滴和视内注射的行为和疗效.
- 了解流体动力学是优化在太空中向眼睛输送药物的关键.
- 眼部药物的药物动力学特征在零重力环境中发生变化.
结论:
- 需要创新的药物输送系统,以便在太空中有效管理眼部疾病.
- 需要进一步的研究,以充分理解和减轻微重力对眼睛治疗的影响.
- 这项工作将流体动力学,微重力和生理学联系在一起,以提高宇航员的眼睛护理.
相关概念视频
Open Angle Glaucoma: Treatment
420
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
420
Biopharmaceutics and Pharmacokinetics: Overview
1.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.9K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
191
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
191
One-Compartment Open Model for IV Bolus Administration: General Considerations
178
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
178
Glaucoma: Overview
532
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
532
Factors Influencing Drug Absorption: Drug Dissolution
454
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
454


